N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline

C78H73N17O5 — CID 157089722

IUPACN-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline
SMILESCC(=O)C1=C(c2ccccc2)CC(c2ccnc(N(C(C)=O)C(C)=O)n2)=C1.CC(=O)n1nc(-c2cnc3ccccc3c2)cc1NC(=O)CC(C)CN1CCCCC1.Cc1cc(-c2cnc3ccccc3c2)n[nH]1.c1ccc2ncc(-c3cc(-c4ccc(C5=NN=NC5)cc4)[nH]n3)cc2c1
InChIInChI=1S/C24H29N5O2.C21H19N3O3.C20H14N6.C13H11N3/c1-17(16-28-10-6-3-7-11-28)12-24(31)26-23-14-22(27-29(23)18(2)30)20-13-19-8-4-5-9-21(19)25-15-20;1-13(25)18-11-17(12-19(18)16-7-5-4-6-8-16)20-9-10-22-21(23-20)24(14(2)26)15(3)27;1-2-4-17-15(3-1)9-16(11-21-17)19-10-18(23-24-19)13-5-7-14(8-6-13)20-12-22-26-25-20;1-9-6-13(16-15-9)11-7-10-4-2-3-5-12(10)14-8-11/h4-5,8-9,13-15,17H,3,6-7,10-12,16H2,1-2H3,(H,26,31);4-11H,12H2,1-3H3;1-11H,12H2,(H,23,24);2-8H,1H3,(H,15,16)
InChIKeyAENGVEUFTWPMRL-UHFFFAOYSA-N
MW1328.56 g/mol
LogP14.81
Rot. Bonds14

About N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline

N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline (PubChem CID 157089722) has the molecular formula C78H73N17O5 and a molecular weight of 1328.56 g/mol. Its IUPAC name is N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline.

Molecular Properties

Compound NameN-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline
PubChem CID157089722
Molecular FormulaC78H73N17O5
Molecular Weight1328.56 g/mol
Exact Mass1327.60
IUPAC NameN-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline
SMILESCC(=O)C1=C(c2ccccc2)CC(c2ccnc(N(C(C)=O)C(C)=O)n2)=C1.CC(=O)n1nc(-c2cnc3ccccc3c2)cc1NC(=O)CC(C)CN1CCCCC1.Cc1cc(-c2cnc3ccccc3c2)n[nH]1.c1ccc2ncc(-c3cc(-c4ccc(C5=NN=NC5)cc4)[nH]n3)cc2c1
InChIInChI=1S/C24H29N5O2.C21H19N3O3.C20H14N6.C13H11N3/c1-17(16-28-10-6-3-7-11-28)12-24(31)26-23-14-22(27-29(23)18(2)30)20-13-19-8-4-5-9-21(19)25-15-20;1-13(25)18-11-17(12-19(18)16-7-5-4-6-8-16)20-9-10-22-21(23-20)24(14(2)26)15(3)27;1-2-4-17-15(3-1)9-16(11-21-17)19-10-18(23-24-19)13-5-7-14(8-6-13)20-12-22-26-25-20;1-9-6-13(16-15-9)11-7-10-4-2-3-5-12(10)14-8-11/h4-5,8-9,13-15,17H,3,6-7,10-12,16H2,1-2H3,(H,26,31);4-11H,12H2,1-3H3;1-11H,12H2,(H,23,24);2-8H,1H3,(H,15,16)
InChIKeyAENGVEUFTWPMRL-UHFFFAOYSA-N
XLogP14.81
TPSA280.57 Ų
H-Bond Donors3
H-Bond Acceptors18
Rotatable Bonds14
Heavy Atoms100
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001328.56
LogP ≤ 514.81
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1018

Analyze N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline?
The IUPAC name of N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline (CID 157089722) is N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline.
What is the SMILES notation for N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline?
The canonical SMILES for N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline is CC(=O)C1=C(c2ccccc2)CC(c2ccnc(N(C(C)=O)C(C)=O)n2)=C1.CC(=O)n1nc(-c2cnc3ccccc3c2)cc1NC(=O)CC(C)CN1CCCCC1.Cc1cc(-c2cnc3ccccc3c2)n[nH]1.c1ccc2ncc(-c3cc(-c4ccc(C5=NN=NC5)cc4)[nH]n3)cc2c1.
What is the InChIKey of N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline?
The InChIKey is AENGVEUFTWPMRL-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H29N5O2.C21H19N3O3.C20H14N6.C13H11N3/c1-17(16-28-10-6-3-7-11-28)12-24(31)26-23-14-22(27-29(23)18(2)30)20-13-19-8-4-5-9-21(19)25-15-20;1-13(25)18-11-17(12-19(18)16-7-5-4-6-8-16)20-9-10-22-21(23-20)24(14(2)26)15(3)27;1-2-4-17-15(3-1)9-16(11-21-17)19-10-18(23-24-19)13-5-7-14(8-6-13)20-12-22-26-25-20;1-9-6-13(16-15-9)11-7-10-4-2-3-5-12(10)14-8-11/h4-5,8-9,13-15,17H,3,6-7,10-12,16H2,1-2H3,(H,26,31);4-11H,12H2,1-3H3;1-11H,12H2,(H,23,24);2-8H,1H3,(H,15,16).
What are the key properties of N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline?
N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline has a molecular weight of 1328.56 g/mol, XLogP of 14.81, 14 rotatable bonds, 3 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-acetyl-N-[4-(3-acetyl-4-phenylcyclopenta-1,3-dien-1-yl)pyrimidin-2-yl]acetamide;N-(1-acetyl-3-quinolin-3-ylpyrazol-5-yl)-3-methyl-4-piperidin-1-ylbutanamide;3-(5-methyl-1H-pyrazol-3-yl)quinoline;3-[5-[4-(4H-triazol-5-yl)phenyl]-1H-pyrazol-3-yl]quinoline is sourced from PubChem (CID 157089722), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).